Biology, care, and outcomes of gestational breast cancers: a review
Breast Cancer Research and Treatment · 2025
DOI: 10.1007/s10549-025-07684-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Niharika Duggirala und 6 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Pregnancy Complications, Neoplastic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terri Brodeur Breast Cancer Foundation.
Abstract (Originalsprache)
Purpose
The incidence of gestational breast cancers, breast cancers diagnosed during pregnancy, is increasing. There is a critical need to understand the pathophysiology, treatment recommendations, and remaining questions regarding care and therapeutics for this complex condition.
Methods
Here, we review existing data regarding evaluation and management of gestational breast cancer, including safe imaging modalities, timing and choice of chemotherapy, evidence regarding targeted therapies during pregnancy. We highlight the importance of multidisciplinary care including oncologic, obstetric, and psychosocial care.
Results
Gestational breast cancers are associated with unique biologic and clinicopathologic features that are impacted by physiologic changes of pregnancy such as upregulation of target genes associated with cell proliferation and immune regulation. Patients with gestational breast cancers more often present at advanced stages, are more likely to have aggressive tumor subtypes (i.e., triple negative or HER2 positive), and overall have worse prognoses than patients with non-gestational breast cancers. In this review, we synthesize recommendations for treatment strategies based on pregnancy trimester, optimal timing and choice of surgery, chemotherapy, targeted therapies, and psychosocial support.
Conclusion
Developing a framework for clinical care and treatment of patients with gestational breast cancers is integral to improving outcomes for patients with gestational breast cancers. Optimal treatment includes collaborative management with a multidisciplinary team dedicated to both maternal and fetal care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
- David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA. MlipsycSharf@mednet.ucla.edu.
Förderung
- Terri Brodeur Breast Cancer Foundation
Zitieren
APA
Duggirala, N., Zhang, S., Master, A., Rao, R., Kapoor, N. S., Bardia, A., & Lipsyc-Sharf, M. (2025). Biology, care, and outcomes of gestational breast cancers: a review. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-025-07684-9
Vancouver
Duggirala N, Zhang S, Master A, Rao R, Kapoor NS, Bardia A, et al. Biology, care, and outcomes of gestational breast cancers: a review. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-025-07684-9
BibTeX
@article{Duggirala2025,
author = {Duggirala, Niharika and Zhang, Shiliang and Master, Aashini and Rao, Rashmi and Kapoor, Nimmi S and Bardia, Aditya and Lipsyc-Sharf, Marla},
title = {Biology, care, and outcomes of gestational breast cancers: a review},
journal = {Breast Cancer Research and Treatment},
year = {2025},
doi = {10.1007/s10549-025-07684-9}
}
EUVIMED